Skip to main content
OpenTrials
Completed

NCT Number: NCT00347984

Product Preference With Systane Compared to Artificial Tears on Frequency of Drop Use

The objective of this study was to evaluate the effect of Systane® compared to marketed artificial tears on the frequency of drop use.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Maryland

Andover, Massachusetts, 01845, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects age 18 (minimum); reported history of dry eye syndrome in both eyes; TFBUT ≤ 7 seconds in at least 1 eye at Visit 1; ≥ 1+ fluorescein staining score in any region in at least 1 eye at Visit 1; desire to use an artificial tear substitute for dry eye symptoms at least 4 times per day at Visit 1 and Visit 2.

Exclusion criteria

  • Age less than 18 years

Treatment and study plan

Systane Lubricant Eye Drops

Other

Primary outcomes

  1. Frequency of drop use and/or desire to use; Drop preference

Secondary outcomes

  1. Product questionnaire; Symptoms; Corneal and conjunctival staining; Tear film break-up time (TFBUT).

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Collaborators

  • ORA, Inc.

Registry information

Official study title

The Effect of Systane® Compared to Marketed Artificial Tears on Frequency of Drop Use

Important dates

Study start
2005
Primary completion
2006
Study completion
2006
First posted
Jul 4, 2006
Registry last updated
Apr 10, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.